Wanrudee Isaranuwatchai

PhD

Director, Centre for Excellence in Economic Analysis Research

Biography

Dr. Wanrudee Isaranuwatchai is a Scientist at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital.

She is an Interim Director and a Health Economist at the Centre for Excellence in Economic Analysis Research (CLEAR), a part of the HUB Health Research Solutions at St. Michael’s Hospital. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto.

Dr. Isaranuwatchai has collaborated with researchers and decision-makers in various topics areas to help communicate the value of health programs/initiatives using economic evidence. She has experience conducting economic evaluations using person-level data and decision modeling. Dr. Isaranuwatchai’s research focuses on applied economic evaluation (e.g., how to make economic evaluation more useful to researchers, health providers, and decision-makers) and health economics methods.

Recent Publications

  1. Mendlowitz, AB, Shanbour, A, Downar, J, Vila-Rodriguez, F, Daskalakis, ZJ, Isaranuwatchai, W et al.. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis. PLoS ONE. 2019;14 (9):e0222546. doi: 10.1371/journal.pone.0222546. PubMed PMID:31513675 .
  2. Isaranuwatchai, W, de Oliveira, C, Mittmann, N, Evans, WKB, Peter, A, Truscott, R et al.. Impact of smoking on health system costs among cancer patients in a retrospective cohort study in Ontario, Canada. BMJ Open. 2019;9 (6):e026022. doi: 10.1136/bmjopen-2018-026022. PubMed PMID:31230002 PubMed Central PMC6596959.
  3. Evans, WK, Truscott, R, Cameron, E, Rana, S, Isaranuwatchai, W, Haque, M et al.. Implementing smoking cessation within cancer treatment centres and potential economic impacts. Transl Lung Cancer Res. 2019;8 (Suppl 1):S11-S20. doi: 10.21037/tlcr.2019.05.09. PubMed PMID:31211102 PubMed Central PMC6546624.
  4. Magnus, A, Isaranuwatchai, W, Mihalopoulos, C, Brown, V, Carter, R. A Systematic Review and Meta-Analysis of Prostate Cancer Utility Values of Patients and Partners Between 2007 and 2016. MDM Policy Pract. ;4 (1):2381468319852332. doi: 10.1177/2381468319852332. PubMed PMID:31192309 PubMed Central PMC6540514.
  5. Hoch, JS, Hay, A, Isaranuwatchai, W, Thavorn, K, Leighl, NB, Tu, D et al.. Advantages of the net benefit regression framework for trial-based economic evaluations of cancer treatments: an example from the Canadian Cancer Trials Group CO.17 trial. BMC Cancer. 2019;19 (1):552. doi: 10.1186/s12885-019-5779-x. PubMed PMID:31174497 PubMed Central PMC6555934.
  6. Tangjitgamol, S, Tharavichitkul, E, Tovanabutra, C, Rongsriyam, K, Asakij, T, Paengchit, K et al.. A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial. J Gynecol Oncol. 2019;30 (4):e82. doi: 10.3802/jgo.2019.30.e82. PubMed PMID:31074236 PubMed Central PMC6543099.
  7. Isaranuwatchai, W, Li, R, Glassman, A, Teerawattananon, Y, Culye, AJ, Chalkidou, K et al.. Disease Control Priorities Third Edition: Time to Put a Theory of Change Into Practice Comment on "Disease Control Priorities Third Edition Is Published: A Theory of Change Is Needed for Translating Evidence to Health Policy". Int J Health Policy Manag. 2018;8 (2):132-135. doi: 10.15171/ijhpm.2018.115. PubMed PMID:30980627 PubMed Central PMC6462203.
  8. Mighton, C, Carlsson, L, Clausen, M, Casalino, S, Shickh, S, McCuaig, L et al.. Development of patient "profiles" to tailor counseling for incidental genomic sequencing results. Eur. J. Hum. Genet. 2019;27 (7):1008-1017. doi: 10.1038/s41431-019-0352-2. PubMed PMID:30846854 .
  9. McGillion, MH, Henry, S, Busse, JW, Ouellette, C, Katz, J, Choinière, M et al.. Examination of psychological risk factors for chronic pain following cardiac surgery: protocol for a prospective observational study. BMJ Open. 2019;9 (2):e022995. doi: 10.1136/bmjopen-2018-022995. PubMed PMID:30826789 PubMed Central PMC6398732.
  10. John-Baptiste, AA, Li, L, Isaranuwatchai, W, Osuch, E, Anderson, KK. Healthcare utilization costs of emerging adults with mood and anxiety disorders in an early intervention treatment program compared to a matched cohort. Early Interv Psychiatry. 2019; :. doi: 10.1111/eip.12790. PubMed PMID:30688032 .
Search PubMed

Affiliations & Other Activities

  • Scientist, Li Ka Shing Institute
  • Assistant Professor, Institute for Health Policy, Management and Evaluation, University of Toronto
X